INTRODUCTION
OCA-B (OBF-1/BOB1) is a B cell-specific coactivator that acts in conjunction with the octamer binding transcription factors OCT-1 and OCT-2. Initial studies revealed a requirement for OCA-B, through OCT-1/2 at the octamer element (5 0 -ATGCAAAT), for optimal immunoglobulin (Ig) gene promoter activity in vitro (Luo et al., 1992 ; reviewed in Luo and Roeder, 1999) . Subsequent studies with Ocab-deficient (Oca-b À/À ) mice showed that OCA-B plays a broad role in B cell development and function (Kim et al., 1996; Schubart et al., 1996; Nielsen et al., 1996) . Surprisingly, IgM expression is largely normal in Oca-b
mice, although OCA-B is required for full activity of a subset of k light-chain promoters (Casellas et al., 2002) . There is also a reduction in the transitional B cell compartment in the spleens of Oca-b À/À mice, perhaps as a consequence of the skewed Igk repertoire and/or a B cell signaling defect (Casellas et al., 2002; Jankovic and Nussenzweig, 2003) .
The most drastic defect in Oca-b À/À mice is observed in the peripheral lymphoid organs during antigen-dependent B cell maturation and effector function. These defects include dramatically diminished levels of IgH secondary isotypes, a complete lack of germinal centers, and impaired antibody responses to both T-independent and T-dependent antigens (Kim et al., 1996; Schubart et al., 1996; Nielsen et al., 1996) . The reduction in secondary-isotype levels is caused by reduced expression of the switched genes and may be attributed in part to OCA-B function at the 3 0 enhancer (Kim et al., 1996; Tang and Sharp, 1999; Stevens et al., 2000) . At the cellular level, Oca-b À/À B cells are deficient in processing B cell antigen receptor (BCR) derived signals, as evidenced by their reduced proliferation following BCR ligation (Kim et al., 1996) . A recent study has identified additional OCA-B target genes that may be involved in these processes (Kim et al., 2003) , although the exact mechanisms by which these genes contribute to B cell signaling and differentiation are not fully understood. Additionally, OCA-B is likely to play a unique role in B cell signaling, as evidenced by the presence of two distinct OCA-B isoforms, one that is predominantly nuclear and another that is myristoylated and present in the cytoplasm (Yu et al., 2001) .
Given that Oca-b À/À B cells are deficient in BCR signaling, it seemed important to determine whether these cells have a similar phenotype relative to pre-BCR signaling since both pathways involve the action of many of the same proteins, such as SYK, PLCg2, FYN, BLK, LCK, and LYN (reviewed in Wang and Clark, 2003) . Furthermore, Igb, which is the signaling component of both the pre-BCR and BCR, has been identified as an OCA-B target gene in mature B cells (Malone and Wall, 2002) . Additionally, and significantly, the signaling proteins BTK and SLP-65, which are also critical for BCR signaling and mature B cell differentiation, have recently been shown to play a role in early B cell development as well (Middendorp et al., 2002; Flemming et al., 2003) . In the current study, an analysis of early B cell surface marker expression and proliferative capacity of Oca-b À/À bone-marrow B cells has revealed defects in the pre-B1-to-pre-B2 cell transition, in pre-BCR signaling, and in IL-7 responsiveness. Levels of expression of recently identified OCA-B target genes, as well as genes involved in pre-BCR signaling, have also been determined in order to access possible contributions to the observed phenotype. This analysis has revealed a severe reduction of the SYK protein level in both early and mature B cells from Oca-b À/À mice and, surprisingly, a direct interaction between SYK and OCA-B. This interaction is particularly unique and indicates a mechanism by which OCA-B, a conventional nuclear transcription coactivator, can also act through SYK, a tyrosine kinase.
RESULTS

OCA-B Controls Early B Cell Development
In mouse bone marrow, developmental progression from the pro-B (B220 + /CD43 + ) to the pre-B (B220 + /CD43 À ) cell stage was associated with a dramatic increase in the level of OCA-B protein ( Figures 1A and 1B) . Furthermore, the expression levels of OCA-B during B cell development correlated directly with the RNA expression levels of known OCA-B target genes such as Cdc37, Cyclin D3, Kcnn4, and Lck ( Figure 1C ). These findings suggested that increased OCA-B expression during early stages of B cell development may contribute to establishment of the gene expression program required for pro-B-to-pre-B cell development.
In an analysis of B cell populations in the bone marrow, Oca-b À/À mice showed reduced frequencies and numbers of pre-B2 (B220 Figure 1D ). In contrast, the OCA-B deficiency led to an increase in pre-B1 (B220 Figure 1D ). Consistent with an increased proportion of B220 + /CD43 + pre-B cells in Oca-b À/À mice, there was also a significant increase both in the number of large cells (on average 25%; p = 0.018) within the bone marrow and in the B220 + compartment (p = 0.012) ( Figure 1E ). Defective pre-B cell development in the bone marrow of Oca-b
mice was accompanied by reduced cellularity of the peripheral B cell compartment and significantly diminished numbers of B cells that recirculate to the bone marrow from the periphery ( Figure 1D ; Hess et al., 2001) . Overall, these findings demonstrate an important role of OCA-B in the pre-B1-to-pre-B2 cell transition and/or in pre-B cell expansion. were sorted and the RNA expression levels of relevant genes were analyzed by qPCR ( Figure 2A ). As expected (Hendriks and Middendorp, 2004) , the surrogate lightchain genes V pre-B and l5 were more highly expressed in pre-B1 cells whereas Iga, Igb, and Cdc37 were more highly expressed in pre-B2 cells ( Figures 2B and 2C Figure 2D ). These results are consistent with the possibility of OCA-B function in early B cell development through regulation of its target genes. Importantly, especially in light of additional findings (below), the RNA levels for other kinases involved in B cell signaling (BTK, LYN, FYN, and SYK) were relatively unaffected by the OCA-B deficiency ( Figure 2D ).
OCA-B Target Genes
Oca-b
À/À Early B Cells Aberrantly Respond to Differentiation Signals Although some alterations in the RNA expression levels of a number of relevant genes were observed, it remained possible that Oca-b À/À mice have additional defects in early B cell signaling. Importantly, phenotypes similar to those observed for Oca-b À/À mice also have been described for Slp-65
, and Irf4 maa et al., 1999; Middendorp et al., 2002; Flemming et al., 2003; Lu et al., 2003) . BTK and SLP-65 play important roles in pre-BCR signaling, as evidenced by impaired pre-BCRmediated responses in Btk À/À and Slp-65 À/À cells cultured in the presence of IL-7 (Jumaa et al., 1999; Middendorp et al., 2002; Flemming et al., 2003) . Providing IL-7 to ex vivo cultured CD19 + cells from bone marrow stimulates proliferation of IL-7Ra-bearing pro-B cells. In vivo, IL-7 is provided by stromal cells and serves to drive proliferation of IL-7Ra-bearing B cells. Furthermore, the pre-BCR and IL-7Ra signaling pathways are tightly linked in that pre-BCR signaling is known to limit IL-7 responsiveness by promoting light-chain rearrangement and differentiation (Marshall et al., 1998; Hendriks and Middendorp, 2004) . In order to further examine signaling in Oca-b À/À mice, we made use of the IL-7 culture system that had been used to study the Btk À/À and Slp-65 À/À mice. Total bone-marrow B cells (CD19 + ) were isolated and cultured for a time course that extended to 168 hr of IL-7 exposure. In this culture system, IL-7-responsive cells typically become larger in size, and this response was essentially normal in the Oca-b À/À cultures (data not shown). Consistent with the high level of OCA-B expression in noncultured pre-B cells ( Figure 1D ), OCA-B was also expressed throughout the IL-7 time course ( Figure 3A) . Strikingly, the Oca-b À/À pre-B cells were found to be markedly hyperproliferative, relative to their wild-type counterparts, in the presence of IL-7 ( Figure 3B ). A similar phenotype also was observed in long-term stromal cell-dependent Oca-b À/À bone-marrow cultures (data not shown). An additional analysis of cell surface marker expression showed an increased percentage of cells expressing the pre-BCR in the Oca-b À/À population after 48 hr of IL-7 exposure (32.3% versus 52.6%) ( Figure 3C ). As expected, CD43 and the pre-BCR were coexpressed on the cell surface, indicating the specificity of the pre-BCR antibody (Figure 3C ). Since pre-BCR signaling is known to limit IL-7-mediated proliferation (Marshall et al., 1998) cells. IL-7 removal in this culture system serves to promote rearrangement of the immunoglobulin light chain (Igk), and this can be used to determine whether pre-BCR signaling is functional (Rolink et al., 1991; Ray et al., 1998) . As previously reported (Hess et al., 2001) , there were fewer IgM
mice as a result of a reduction in the recirculating B cell pool ( Figure 3D ). As expected, by 52 hr post-IL-7 removal, the wild-type culture had reestablished a m + /k + population (10%) ( Figure 3D ). This differentiation step did not occur (within the given time period) in the rapidly proliferating In light of the similar phenotypes of Oca-b À/À mice, our demonstration that OCA-B plays a role in pre-BCR signaling, and a block in early B cell development of Syk À/À mice (Cheng et al., 1995; Turner et al., 1995; Saijo et al., 2003) , we examined Syk À/À cells in the IL-7 culture. For this analysis, we used Syk conditional knockout (Syk À/À ) mice that had been generated using Cre-mediated recombination (Saijo et al., 2003) . Interestingly, Syk À/À cells also were hyperproliferative in response to IL-7 ( Figure 3B ). Altogether, these results suggest that OCA-B might function in pre-BCR signaling through a mechanism involving SYK, BTK, or SLP-65. 
Genes that are induced in pre-B1 cells and pre-B2 cells are shown in (B) and (C), respectively. The values shown are averages generated from three to five independent experiments. Error bars represent standard deviations. (D) A similar method was used to determine the difference in expression of these genes between Oca-b +/+ and Oca-b À/À cells using the equation
have fewer transcripts relative to wild-type cells. The values shown are averages generated from three to five independent experiments. ND, not determined.
Pre-BCR Signaling Is Compromised in Oca-b À/À Cells
In order to determine the mechanism by which OCA-B functions in pre-BCR signaling, we directly measured pre-BCR signaling capacity in CD19 + bone-marrow cells that were cultured in IL-7 for 48 hr to allow accumulation of pre-BCR + cells (30%-50% CD19 Figure 3D ). To avoid crosslinking the mature BCR, k + cells were depleted after 48 hr of IL-7 culture. Flow cytometry analysis of the depleted population confirmed a near absence of mature cells (98% purity; data not shown). The pre-BCR was then crosslinked, and, as expected, pre-BCR signaling measured by global tyrosine phosphorylation peaked at 2 min in the wild-type samples ( Figure 4A , upper panel). Crosslinking of the Oca-b À/À cells resulted in greatly reduced tyrosine phosphorylation, suggesting a possible reduction in expression and/or activity of protein tyrosine kinases ( Figure 4A , upper panel). Remarkably, we found that the SYK protein level was severely reduced in Oca-b À/À pre-B cells even in the absence of pre-BCR activation ( Figure 4A , lower panel). The expression of LCK, the product of an OCA-B target gene, also was reduced, albeit less dramatically, while FYN and ERK expression levels were unaffected ( Figure 4A , lower panel). A significant reduction of SYK expression was also apparent in freshly isolated pre-B cells, indicating that the reduction in SYK expression is not a by-product of culture in IL-7 ( Figure 4C ). Because OCA-B is primarily known for its role in transcription, it was of interest to determine whether the SYK RNA level is also affected in the IL-7 cultured cells. Interestingly, qPCR indicated that the SYK RNA level was reduced only marginally (2.9-fold), relative to the SYK protein level, after 48 hr of culture ( Figure 4B ). This coincides with the moderate reduction (2.6-fold) observed in freshly isolated pre-B cells ( Figure 2D ). Although two nonconsensus octamer sites were identified in the predicted Syk promoter region, occupancy of these sites by OCT or OCA-B was not observed in IL-7-cultured primary cells or in the murine lymphoblastic A20 cell line by chromatin immunoprecipitation assays (data not shown). Given that the these assays were negative and that qPCR showed a very marginal difference in SYK RNA levels in vivo ( Figure 2D and Figure 4B ), we conclude that Syk is not a transcriptional target of OCA-B. mice have compromised tyrosine phosphorylation, calcium flux, and proliferation in response to BCR stimulation. Additionally, these mice have compromised responses to T-dependent antigens (reviewed in Teitell, 2003) . To explore the possibility that reduced SYK protein levels in Oca-b À/À mice might contribute to these defects, splenic B cells were isolated and cultured for up to 120 hr with anti-IgM (BCR stimulation); anti-IgM, anti-CD40, and IL-4 (costimulation to mimic T cell-dependent signaling); or LPS ( Figures 4D-4F ). Analysis of the SYK expression levels by immunoblot revealed marked reductions in the SYK protein level for all of the activation conditions tested ( Figures 4D-4F ). In contrast, the protein levels of other kinases such as LYN, FYN, and ERK were not affected by the OCA-B deficiency ( Figures 4D-4F and data not shown). Importantly, SYK is dynamically regulated in the wild-type cells that have received costimulation (Figure 4E) , which is consistent with this type of stimulation promoting proliferation and differentiation as opposed to proliferation alone during stimulation with anti-IgM or LPS. These data indicate that the specific reduction of SYK protein is likely to contribute to the reduced responsiveness of Oca-b À/À mice to BCR stimulation and T-dependent antigens.
OCA-B Directly Regulates SYK Protein Stability
Since the SYK protein level was affected at multiple stages of B cell development (early and peripheral B cells) and because Syk is not a transcriptional target of OCA-B, it was necessary to consider alternative mechanisms by which OCA-B could regulate SYK. Importantly, SYK is heavily regulated at the level of protein stability through proteasome-dependent pathways in many hematopoietic cell types (reviewed in Rao et al., 2002) . To initiate ubiquitin-mediated degradation, SYK is tyrosine phosphorylated at residue 317 by LYN, which then allows SYK to be targeted by the E3 ubiquitin ligase CBL-B (reviewed in Rao et al., 2002) . To explore the possibility that OCA-B may affect SYK protein levels through this degradation pathway, the level of SYK that is phosphorylated at residue 317 was examined. Indeed, there was a significant increase of this form of SYK in the Oca-b À/À cells ( Figure 4D ).
The increased phosphorylation at this site in mature B cells from Oca-b À/À mice indicates that SYK is less stable in the absence of OCA-B. In order to confirm that the alterations in SYK protein levels in Oca-b À/À mature B cells are a direct result of reduced SYK protein stability, we analyzed SYK degradation in resting B cells cultured in the presence of cycloheximide and anti-IgM ( Figure 4G ). Analysis of SYK protein levels by immunoblot indicated that SYK is highly unstable in Oca-b À/À cells relative to wildtype cells ( Figure 4G ). Because OCA-B directly regulates SYK protein stability, it is important to note that B cells contain two OCA-B isoforms that arise from different translation start sites (Yu et al., 2001 ). The larger form, p35, is myristoylated and is localized predominantly to the cytoplasm and plasma membrane (Yu et al., 2001) ; therefore, it is plausible that OCA-B and SYK could interact in the cytoplasm or at the membrane. To investigate this possibility, we performed immunofluorescence microscopy to determine whether OCA-B and SYK colocalize. Namalwa cells, a human Burkitt's lymphoma B cell line, were used for these experiments. The localization of IgM, SYK, and OCA-B was analyzed over a time course of anti-IgM stimulation or anti-IgM, anti-CD40, and IL-4 costimulation. Analysis of IgM fluorescence after anti-IgM stimulation showed a characteristic aggregation of IgM, and, as expected, SYK and IgM also colocalized to the membrane (Figure 5A) . Furthermore, colocalization of OCA-B and IgM was frequently observed upon stimulation with anti-IgM or anti-IgM, anti-CD40, and IL-4 ( Figures 5A and 5B) . Interestingly, a significant number of cells (p = 0.0057) showed a strong cytoplasmic localization of OCA-B by the end of the anti-IgM stimulation time course ( Figure 5C , blue). There was also a significant increase of cells with OCA-B in this configuration during costimulation ( Figure 5B) ; however, the change in localization was more rapid, occurring within 10 min (p = 0.004) ( Figure 5C, red) . Colocalization of SYK and OCA-B could be observed in cells that had strong cytoplasmic staining of OCA-B ( Figure 5A and 5B). Interestingly, some of the cells showed both nuclear and cytoplasmic staining for SYK ( Figure 5A ). This correlates with the finding that Namalwa nuclear extracts have a significant amount of SYK, as detected by immunoblot (data not shown). Similar results were also obtained by imaging Daudi cells, another Burkitt's lymphoma cell line (data not shown).
OCA-B and SYK Interact Directly
To confirm that the observed colocalization of SYK and OCA-B represents a protein-protein interaction, we performed immunoprecipitation experiments with whole-cell extracts from Oca-b +/+ splenocytes that had been stimulated with anti-IgM for up to 5 hr. SYK was immunoprecipitated with OCA-B at t = 0 and showed an increased level of coimmunoprecipitation that was coincident with increased tyrosine phosphorylation for up to 10 min ( Figure 6A ). By 2 hr, the amount of SYK associated with OCA-B was roughly back to that of the resting state (t = 0) ( Figure 6A ). Because SYK expression is reduced in Oca-b À/À mature B cells that have been activated in culture for long periods of time, the interaction between OCA-B and SYK was analyzed in the context of longer costimulation with anti-IgM, anti-CD40, and IL-4. Immunoblot analysis of the derived extracts revealed that the interaction decreased between 5 and 65 hr of activation. Thus, by 40 hr, the association of SYK and OCA-B was marginal compared to t = 0, and by 65 hr, SYK protein was no longer present in the immunoprecipitate ( Figure 6B ). The dramatic induction of OCA-B expected at later time points of costimulation (Kim et al., 2003) also was observed. In order to determine whether the interaction between SYK and OCA-B is direct, we performed GST-pull-down experiments using bacterially expressed GST-OCA-B fusion proteins and bacterially expressed His-tagged fulllength SYK. GST-OCA-B fusion proteins were purified and normalized for the pull-down according to the amount of full-length product ( Figure 6C ). The pull-down showed a direct interaction between SYK and OCA-B, with SYK having the highest affinity for the C terminus of OCA-B ( Figure 6D ), indicating that SYK protein stability is regulated by direct interaction with the OCA-B transcriptional activation domain.
Since OCA-B and SYK are colocalized in the cytoplasm after stimulation with anti-IgM or anti-IgM, anti-CD40, and IL-4 ( Figures 5A and 5B) , it was of interest to determine whether SYK preferentially associates with OCA-B p35, the myristoylated form, relative to OCA-B p34. Ni-NTA pull-down assays were performed using His-tagged fulllength SYK and either whole-cell (WCE), cytoplasmic (S100), or nuclear (NE) extracts from Namalwa cells. Full-length SYK was able to pull down both forms of OCA-B with relatively equal efficiencies ( Figure 6E ). These data are consistent with a strong OCA-B interaction with SYK through a C-terminal domain that is the same for both forms of OCA-B.
Given the reduced nuclear staining of OCA-B in Namalwa cells upon stimulation ( Figure 5C ), the interaction between OCA-B and SYK was analyzed by anti-OCA-B immunoprecipitation with whole-cell extracts from antiIgM-stimulated Namalwa cells. This analysis revealed an increased OCA-B-SYK association that correlated with the increase in cytoplasmic OCA-B ( Figure 6F , upper panel). Interestingly, an immunoblot for phosphotyrosine revealed that phosphorylated SYK does not coimmunoprecipitate with OCA-B ( Figure 6F , pTYR, lower panel). Importantly, this indicates that SYK has not yet been phosphorylated by BCR signaling when it interacts with OCA-B. To examine the interaction between OCA-B and SYK in more detail, the SYK domain that interacts with OCA-B was mapped. His-tagged SYK proteins were generated in a manner consistent with the domains of SYK. Other than full-length SYK, only SYK fragments containing the kinase domain are able to efficiently pull down both forms of OCA-B from cytoplasmic extracts (S100) (Figures 6E and 6G) . Of the kinase-domain-containing SYK fragments, those containing the C-terminal portion of the kinase domain are able to interact with OCA-B most efficiently ( Figure 6G ).
Although both isoforms of OCA-B are able to interact with SYK in vitro (Figure 6 ), it remains possible that there could be preferential association of one form with SYK in vivo. To address this possibility, BAC-transgenic mice that specifically express OCA-B/p35 or OCA-B/p34 in B cells were generated on the Oca-b À/À background. In this way, loss of function of one form can be assessed using BAC clones in which the OCA-B locus has been genetically modified by introducing point mutations in one of the two translation start sites. We have confirmed that the transgenic mice obtained have the expected pattern and selectivity of OCA-B expression (data not shown). To examine SYK regulation in these mice, CD19
+ cells were harvested from bone marrow and cultured in the presence of IL-7 (Figure 7) . All of the transgenes Tg p34 , and Tg p35 ) were able to rescue the hyperproliferation defect of Oca-b À/À mice ( Figure 7A ). Consistent with the in vitro interaction data, the OCA-B p34 and p35 transgene products were both able to stabilize SYK in Oca-b À/À mice ( Figure 7B ).
DISCUSSION
Role of OCA-B in Early B Cell Differentiation and Pre-BCR Signaling
The finding that a substantial fraction of cellular OCA-B is localized to the cytoplasm and membrane (Yu et al., 2001 ) strongly suggests that OCA-B has multiple roles in the cell and can function in processes other than transcription. The identification of a novel interaction between OCA-B and SYK supports this notion and has the potential to explain many aspects of the Oca-b À/À phenotype-including the defects in early B cell development that are presented in this study. Early B cell development is marked by characteristic changes in cellular phenotype that are regulated by a series of antigen-independent checkpoints mediated by cell signaling pathways and dependent on the successful rearrangement of the Ig locus (Hardy and Hayakawa, 2001 ). Expression and signaling from the pre-BCR mediates the progression of developing B cells, first into large (cycling) pre-B1 cells and then into small pre-B2 cells in which light-chain rearrangement occurs.
The pre-B1-to-pre-B2 transition is marked not only by a change in cell size but by changes in the display of cell surface markers such as CD43, c-Kit, CD2, pre-BCR, and CD25 (IL-2R) (Hardy and Hayakawa, 2001 Hendriks and Middendorp, 2004) . More importantly, this type of block, although more severe, has also been described in Syk À/À mice (Cheng et al., 1995; Turner et al., 1995; Saijo et al., 2003) .
OCA-B is known to play a role in BCR signaling, as evidenced by studies showing that Oca-b À/À cells have reduced responsiveness to this signaling pathway (Kim et al., 1996) , and this could be due in part to the OCA-B-SYK interaction. Additionally, many of the OCA-B target genes (such as Lck, Cyclin D3, Cdc37, and Kcnn4) that are induced by BCR stimulation have now been shown to be expressed in pre-B cells. With this in mind, it seemed likely that the newly identified developmental block could be due to the role of OCA-B in pre-BCR signaling. In mice, IL-7-mediated signaling promotes cellular proliferation and survival of IL-7Ra-bearing B cells (Rolink et al., 1991; Ray et al., 1998) . Highly relevant to this study, it is suspected that pre-BCR signaling eventually leads to the termination of IL-7-induced proliferation via an SLP-65-BTK-dependent pathway (Marshall et al., 1998; Fleming and Paige, 2002) .
As reported for Btk À/À and Slp-65 À/À cells in the IL-7 culture system (Middendorp et al., 2002; Flemming et al., 2003) , culture. This finding not only mimics the phenotype observed in vivo but further suggests that there is a buildup of these cells due to inefficient mediation of IL-7Ra signaling by the pre-BCR in the deficient cells. As mentioned previously, another major outcome of pre-BCR signaling is to promote Ig light-chain rearrangement, which, if successful, is followed by display of the mature BCR on the cell surface; SYK exerts a major function in this signaling process, which is defective in the Oca-b À/À cells. Furthermore, pre-BCR signaling mediates downregulation of the surrogate light-chain genes V pre-b and l5 in pre-B2 cells (reviewed in Hendriks and Middendorp, 2004) (Schubart et al., 1996; Kim et al., 2000) . Interestingly, while Syk À/À mice can accumulate immature B cells in the periphery, they fail to enter follicles or the recirculating B cell pool (Turner et al., 1997) . Therefore, it is possible that the reduced stability and resulting decrease of the SYK protein level in Oca-b À/À B cells contributes to the decrease in follicular and recirculating B cells in Oca-b À/À mice. In the case of costimulation to mimic T cell-dependent activation, wild-type cells show a reduction in SYK by 65 hr. This change correlates with differentiation of these cells, as evidenced in part by increased IgG1 transcription (Kim et al., 2003) . The more dramatic reduction of SYK protein levels in the Oca-b À/À cells may contribute to the compromised antigen-dependent immune response of Oca-b À/À mice.
Mechanism of OCA-B-SYK Interaction
The deduced mechanism by which OCA-B regulates SYK protein levels is surprising since SYK is not a transcriptional target of OCA-B on the basis of qPCR and chromatin immunoprecipitation assays. Because of this, alternative functions of OCA-B, both direct and indirect, must be considered. The most obvious evidence to support a direct effect of OCA-B on SYK protein stability is that the two proteins strongly interact, as shown in vitro by assays with bacterially expressed (unmodified) forms at high salt concentrations and in vivo by coimmunoprecipitation. Also, SYK is heavily regulated at the protein level by ubiquitin-mediated degradation by CBL, a RING-finger ubiquitin ligase that binds to SYK that has been tyrosine phosphorylated in its linker region (residue 317) (reviewed in Rao et al., 2002) . Importantly, we have demonstrated that SYK stability is reduced and that SYK phosphorylated at residue 317 is increased in Oca-b À/À mature B cells stimulated by anti-IgM. This increase in phosphorylated SYK and the decrease in total SYK levels due to SYK instability in the Oca-b À/À cells may reflect an inability of OCA-B to interact with and stabilize SYK. This stabilization most likely affects the inactive form of SYK because OCA-B interacts with unphosphorylated SYK through its kinase domain. This would represent a unique and novel mechanism by which SYK protein levels are maintained for activation upon BCR stimulation.
Another interesting aspect of the interaction between SYK and OCA-B is that the interaction increases upon BCR signaling and can occur with either form of OCA-B. Consistent with the finding that the OCA-B C terminus, which is constant in both forms of OCA-B, is most important for interaction with SYK, pull-down and immunoprecipitation assays showed that SYK can interact with both the myristoylated p35 and p34 forms of OCA-B while rescue experiments in Oca-b À/À mice showed that both forms of OCA-B are able to stabilize SYK in vivo and rescue the IL-7 hyperproliferation defect. Additionally, immunofluorescence analyses show colocalization of OCA-B and SYK in Namalwa cells following stimulation by antiIgM or costimulation with anti-IgM, anti-CD40, and IL-4. The Namalwa cells show responsiveness to BCR signaling in that IgM becomes more aggregated with treatment. The significantly increased incidence of cells with ''nuclear exclusion'' of OCA-B following BCR stimulation is likely to be related to its interaction with SYK because increased association between OCA-B and SYK is detected by immunoprecipitation using extracts from these cells. Possibly related to this idea, there is also a fraction of cells that have strong nuclear staining for SYK. Nuclear localization of SYK has been reported previously and is dependent on a nuclear localization signal in the linker region (Ma et al., 2001; , although the functional significance of this finding has not been fully determined. Further investigation into the translocation of OCA-B within the cell could provide yet another example of the unique behavior of this transcriptional cofactor and could also reveal alternative functions for SYK.
Dual Function of OCA-B in B Cell Signaling
Although OCA-B is best known for its function as a transcription coactivator (Luo and Roeder, 1999) , this study provides further evidence that OCA-B can function by multiple mechanisms within the cell. As a transcription factor, OCA-B activates a subset of genes that are important in cell signaling (Kim et al., 2003) . Although there is also a severe reduction in LCK RNA and protein levels in Oca-b À/À pre-B cells, Lck À/À mice display a normal pre-B1-to-pre-B2 transition and grow normally in an IL-7 culture (data not shown). Therefore, the reduction in LCK is not likely to be responsible for the defects in pre-B cell differentiation in Oca-b À/À mice. However, regulation of OCA-B target genes has been shown to be important for other aspects of B cell differentiation-in particular, mature B cell function (Teitell, 2003) . Interestingly, the OCA-B-SYK interaction occurs early during B cell activation, when OCA-B expression is relatively low. When OCA-B expression is at the highest level, later in the activation program, not only is the OCA-B-SYK interaction no longer apparent, but the transcriptional targets of OCA-B start to be induced ( Figure 6 and Kim et al., 2003) . These findings indicate that OCA-B plays dual roles in the cell, making it broadly important for B cell signaling. Not only can it regulate early events in intracellular signaling by direct interaction with signaling components (SYK), it can also function classically as a transcription coactivator on downstream target genes at later stages of B cell activation.
EXPERIMENTAL PROCEDURES
Animals Eight-to ten-week-old female Oca-b À/À mice (Kim et al., 1996) and C57BL/6J mice were used for all experiments. Syk conditional knockout mice were also used (Syk
) (Saijo et al., 2003) . All mice were maintained under specific-pathogen-free conditions at the Laboratory Animal Research Center at The Rockefeller University.
Flow Cytometry Analysis and Cell Sorting
Bone-marrow cells were flushed from the femurs and tibia of 5-8 mice using PBS. Cell suspensions were prepared for staining according to standard procedures . Cell surface markers were detected using the following antibodies (all from BD PharMingen): B220-PE, CD43-FITC, CD117-APC, IgM-APC, CD19-PE, CD25-APC, IgD-PE, pre-BCR (clone SL-156) streptavidin-PE, and k-PE. For size analysis, large cells were gated (FSC-H > 375) and the percentages obtained were used in a Student's t test to determine statistical significance. For sorting, total bone-marrow cells from 10-12 female mice were isolated and sorted based on staining using the FACS Vantage SE (BD Biosciences). Dead cells and doublets were excluded on the basis of propidium-iodide incorporation and laser scatter patterns, respectively. Postsort analysis was performed to access the purity of all the fractions collected.
RT-PCR and qPCR
RT-PCR was carried out according to standard protocols using cycle numbers within the linear range of amplification for each gene, as determined by qPCR (Kim et al., 2003) . qPCR was performed as described (Kim et al., 2003) , with minor modifications. For these experiments, the reference gene was Gapdh, although similar results were obtained using the gene encoding the RBP5 subunit of RNA polymerase II.
Primary B Cell Culture CD19 + B cells from bone marrow were isolated by MACS (Miltenyi Biotec) and cultured without feeder cells using RPMI supplemented with 20% FBS, 0.05 mM b-ME, 100 U/ml P/S, and 5 ng/ml recombinant IL-7 (Sigma). Fresh IL-7 was added every 72 hr. Flow cytometry was performed as above. Splenocytes were harvested and B cells were enriched by complement-mediated lysis of Thy-1 + cells followed by a Percoll gradient either to separate dead cells and debris or to fractionate resting B cells ( Figure 4G ). Preparations were determined to contain at least 92% live B220 + cells by flow cytometry. The cells were stimulated as described previously (Kim et al., 2003) . To analyze protein stability, cycloheximide was added at a concentration of 10 mg/ml.
Pre-BCR Crosslinking and Immunoblotting CD19 + cells were cultured in IL-7-containing media for 48 hr. Cultures were then depleted of Igk + cells using biotinylated anti-k (BD Pharmingen) conjugated to streptavidin Dynabeads (Dynal Biotech). Depleted fractions were washed and cultured for 4 hr without serum and IL-7 and then stimulated at 37ºC with 10 mg/ml anti-IgM F(ab 0 ) 2 (Pierce Biotechnology). The cells were washed with PBS/1 mM Na 3 VO 4 and lysed with NP40/vanadate buffer (1.5% NP40, 1 mM PMSF, 1 mM NaF, 1 mM Na 3 VO 4 , and 20 mM leupeptin). Tyrosine phosphorylation was accessed using anti-phosphotyrosine (4G10, Upstate Biotechnology). Blots were stripped and then probed with antibodies (all from Santa Cruz Biotechnology) to OCA-B (C-20), SYK (N-19), LCK (sc-13), FYN (fyn3), ERK (C-14), phospho-SYK (Tyr317) (Cell Signaling Technologies), or actin (Sigma).
Protein-Protein Interaction Studies
For immunoprecipitation, lysates were incubated with anti-OCA-B, anti-SYK, or rabbit IgG (control) for 2 hr followed by incubation with protein A Sepharose (Amersham). The immunoprecipitate was then washed four times with lysis buffer, resolved by SDS-PAGE, and analyzed by immunoblot. cDNAs encoding OCA-B residues 1-256, 1-154, and 154-256 or SYK 1-629 were inserted into the GX41 or PET28a plasmids, respectively. The proteins were expressed and purified from E. coli according to standard procedures. For the GST-proteinprotein interaction experiments, 10 mg of GST-OCA-B protein was bound to glutathione Sepharose (Amersham) and incubated with approximately 250 ng of purified His 6 -tagged SYK for 3 hr at 4ºC. The beads were washed six times with binding buffer (20 mM Tris-HCl [pH 7.4], 20% glycerol, 0.2 mM EDTA, 0.1% NP40, 0.2 mM PMSF, and 400 mM KCl). The bound proteins were resolved by SDS-PAGE and analyzed by immunoblot. For the Ni-NTA pull-down experiments, 10 mg of purified His-tagged SYK was incubated with extracts from Namalwa cells for 3 hr in binding buffer (20 mM Tris-HCl [pH 7.4], 10% glycerol, 30 mM imidazole, 0.1% NP40, 1.0 mM PMSF, 0.2 mg/ml BSA, and 150 mM NaCl). The beads were washed six times with binding buffer, and bound proteins were resolved by SDS-PAGE and analyzed by immunoblotting. Cytoplasmic and nuclear extracts were prepared according to standard procedures (Dignam et al., 1983) .
Immunofluorescence Microscopy Namalwa cells were treated with goat anti-human IgM F(ab 0 ) 2 (Southern Biotechnology) or with anti-human IgM F(ab 0 ) 2 , anti-human CD40, and recombinant human IL-4 for various lengths of time before fixation with 2% PFA. Cells were permeabilized using 0.5% saponin and incubated with anti-SYK (4D10) and/or anti-OCA-B (C-20) (Santa Cruz Biotechnology). The secondary antibodies used were Alexa Fluor 488-conjugated chicken anti-rabbit IgG, Alexa Fluor 488-conjugated chicken anti-mouse IgG, Alexa Fluor 546-conjugated goat anti-rabbit IgG, and Alexa Fluor 546-conjugated donkey anti-goat IgG.
